Engineering Resistance to HIV-1 Infection with a Dual Therapeutic Lentiviral Vector

被引：0

作者：

Burke, Bryan P. ^{[1
]}

Boyd, Maureen P. ^{[1
]}

Millington, Michelle L. ^{[1
]}

Impey, Helen ^{[1
]}

Zhang, Jane ^{[1
]}

Carroll, Maria V. ^{[1
]}

Camba-Colon, Joanna ^{[1
]}

Keech, Naomi ^{[1
]}

Delebecque, Frederic ^{[1
]}

Wolstein, Orit ^{[1
]}

Howe, Annett ^{[1
]}

Koldej, Rachel ^{[1
]}

Nicolson, Tamara ^{[1
]}

Levin, Bernard R. ^{[2
,3
]}

Rezek, Valerie ^{[2
,3
]}

Vatakis, Dimitrios N. ^{[2
,3
]}

Kitchen, Scott G. ^{[2
,3
]}

Breton, Louis R. ^{[1
]}

Bartlett, Jeffrey S. ^{[1
]}

Symonds, Geoff P. ^{[1
]}

机构：

[1] Calimmune Inc, Los Angeles, CA USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, UCLA CFAR, Los Angeles, CA 90095 USA

来源：

MOLECULAR THERAPY | 2013年 / 21卷

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：S20 / S20

页数：1

共 50 条

[21] Therapeutic targets for HIV-1 infection in the host proteome
Winnie S Liang
Anil Maddukuri
Tanya M Teslovich
Cynthia de la Fuente
Emmanuel Agbottah
Shabnam Dadgar
Kylene Kehn
Sampsa Hautaniemi
Anne Pumfery
Dietrich A Stephan
Fatah Kashanchi
Retrovirology, 2
[22] Viral loads in dual infection with HIV-1 and cytomegalovirus
Boriskin, YS
Sharland, M
Dalton, R
duMont, G
Booth, JC
ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 80 (02) : 132 - 136
[23] Dual modes of resistance to an HIV-1 fusion inhibitor
Steger, H. K.
Root, M. J.
ANTIVIRAL THERAPY, 2008, 13 (04) : A66 - A66
[24] Monocyte phenotype and extracellular vesicles in HIV-1, HIV-2, and HIV-1/2 dual infection
Honge, Bo L.
Andersen, Morten N.
Petersen, Mikkel S.
Jespersen, Sanne
Medina, Candida
Te, David D. S.
Kjerulff, Bertram
Laursen, Alex L.
Moller, Holger J.
Wejse, Christian
Krarup, Henrik
Moller, Bjarne K.
Erikstrup, Christian
AIDS, 2023, 37 (12) : 1773 - 1781
[25] HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector
Anderson J.
Akkina R.
AIDS Research and Therapy, 2 (1)
[26] Multiclass primary antiretroviral drug resistance in a patient presenting HIV-1/2 dual infection
Castro, Erika
Recordon-Pinson, Patricia
Cavassini, Matthias
Fleury, Herve
ANTIVIRAL THERAPY, 2012, 17 (03) : 593 - 594
[27] HIV-1 in plasma and genital tract of women: Dual infection and drug resistance in different compartments
Weiser, B
Burger, H
Chappey, C
Anastos, K
Mayers, D
Kitchen, C
Meyer, WA
Paxinos, E
Petropolis, C
Chen, CH
Fang, G
CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1222 - 1222
[28] Effect of polyanion-resistance on HIV-1 infection
Bobardt, MD
Armand-Ugón, M
Clotet, I
Zhang, Z
David, G
Este, JA
Gallay, PA
VIROLOGY, 2004, 325 (02) : 389 - 398
[29] Clinical significance of drug resistance in HIV-1 infection
Kuritzkes, DR
AIDS, 1996, 10 : S27 - S31
[30] Gene therapy of HIV-1 infection using lentiviral vectors expressing anti-HIV-1 genes
Mautino, MR
Morgan, RA
AIDS PATIENT CARE AND STDS, 2002, 16 (01) : 11 - 26

← 1 2 3 4 5 →